DarioHealth reports Q1 EPS ($1.25), consensus (85c)

Reports Q1 revenue $5.58M, consensus $5.46M. “The first quarter of 2026 was our second consecutive quarter of sequential revenue growth, alongside continued reductions in operating expenses. Our channel partner ecosystem now provides access to more than 116 million covered lives through blue-chip partners such as Solera and Amwell. These relationships are expanding our reach into leading national and regional payer organizations across the U.S., while strengthening our ability to scale through trusted, established market access channels,” said Erez Raphael, Dario’s CEO.